Shockwave Medical (Ticker: SWAV) is a medical device company that focuses on developing and commercializing innovative technologies to treat complex cardiovascular conditions. The company's flagship product, Intravascular Lithotripsy (IVL), utilizes sonic pressure waves to safely and effectively treat calcified plaque in blood vessels, improving patient outcomes and reducing the need for invasive procedures.

In terms of technical analysis, the stock of Shockwave Medical is currently attempting a breakout. The stock price is approaching the key resistance level of $320, and if it surpasses this level, it could indicate a potential upward movement. This breakout suggests a bullish bias in the market, with the possibility of the stock price reaching $420 in the future.

Given the potential breakout, investors and traders may consider this as an opportunity to capitalize on the stock's upward momentum. However, it is important to closely monitor any potential market developments or news that could impact Shockwave Medical's performance.